Board Meeting19 May 2026, 07:01 pm
Anthem Biosciences Approves FY26 Financial Results, ₹2 Dividend
AI Summary
Anthem Biosciences Ltd's board approved standalone and consolidated financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of ₹2.00 per equity share, subject to shareholder approval. The board also approved the allotment of 14,81,250 equity shares under the ESOP plan, re-appointment of internal auditors, and continuation/re-appointment of directors, subject to shareholder approval.
Key Highlights
- Board approved audited standalone and consolidated financial results for FY26.
- Final dividend of ₹2.00 per share recommended, subject to shareholder approval.
- 14,81,250 equity shares allotted under the Anthem Employee Stock Option Plan 2024.
- Ravikant Uppal's continuation as Non-Executive Independent Director recommended.
- Ravindra Chandrappa's re-appointment as Whole Time Director recommended.
Price Impact
More from ANTHEM